Correlation Between Sunshine Biopharma and Aytu BioScience
Can any of the company-specific risk be diversified away by investing in both Sunshine Biopharma and Aytu BioScience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunshine Biopharma and Aytu BioScience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sunshine Biopharma and Aytu BioScience, you can compare the effects of market volatilities on Sunshine Biopharma and Aytu BioScience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunshine Biopharma with a short position of Aytu BioScience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunshine Biopharma and Aytu BioScience.
Diversification Opportunities for Sunshine Biopharma and Aytu BioScience
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sunshine and Aytu is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Sunshine Biopharma and Aytu BioScience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aytu BioScience and Sunshine Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunshine Biopharma are associated (or correlated) with Aytu BioScience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aytu BioScience has no effect on the direction of Sunshine Biopharma i.e., Sunshine Biopharma and Aytu BioScience go up and down completely randomly.
Pair Corralation between Sunshine Biopharma and Aytu BioScience
Given the investment horizon of 90 days Sunshine Biopharma is expected to under-perform the Aytu BioScience. In addition to that, Sunshine Biopharma is 2.4 times more volatile than Aytu BioScience. It trades about -0.09 of its total potential returns per unit of risk. Aytu BioScience is currently generating about -0.14 per unit of volatility. If you would invest 323.00 in Aytu BioScience on September 1, 2024 and sell it today you would lose (162.00) from holding Aytu BioScience or give up 50.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sunshine Biopharma vs. Aytu BioScience
Performance |
| Timeline |
| Sunshine Biopharma |
| Aytu BioScience |
Sunshine Biopharma and Aytu BioScience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sunshine Biopharma and Aytu BioScience
The main advantage of trading using opposite Sunshine Biopharma and Aytu BioScience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunshine Biopharma position performs unexpectedly, Aytu BioScience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aytu BioScience will offset losses from the drop in Aytu BioScience's long position.| Sunshine Biopharma vs. Tff Pharmaceuticals | Sunshine Biopharma vs. Eliem Therapeutics | Sunshine Biopharma vs. Inhibrx | Sunshine Biopharma vs. Enliven Therapeutics |
| Aytu BioScience vs. Aquestive Therapeutics | Aytu BioScience vs. Evoke Pharma | Aytu BioScience vs. Shionogi Co Ltd | Aytu BioScience vs. Sunshine Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |